just a reminder about recent sales revenue from the old dog, 3tc
2008 3tc sales by GSK were US$1.06B (7% decline from 2007)
Shire received US$140M for HIV and US$40M for HepB
or about 17% royalty
2009Q2 Shire received US$39M
Independent report estimated atc could get US$650M sales and avx could get 12-15% of that...
what will atc sell and what will avx get, and when???
Add to My Watchlist
What is My Watchlist?